George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 307.40
Bid: 306.40
Ask: 306.60
Change: 17.60 (6.07%)
Spread: 0.20 (0.065%)
Open: 296.00
High: 308.70
Low: 295.50
Prev. Close: 289.80
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2022/23 Bank of England stress test results

12 Jul 2023 07:22

RNS Number : 7730F
NatWest Group plc
12 July 2023
 

 

NatWest Group plc

12 July 2023

 

NatWest Group plc

 

2022/23 Bank of England stress test results

 

12 July 2023

 

NatWest Group ("the Group") notes the announcement made today by the Bank of England ("BoE") regarding the results of its 2022 stress test. The test explores whether the Group has sufficient capital to withstand a severe but plausible outcome starting with the Group's balance sheet as at 30 June 2022, and compares the theoretical Common Equity Tier 1 ("CET1") ratio and Tier 1 leverage ratio positions of the Group before and after the impact of strategic management actions.

 

The 2022/23 stress test also assesses NatWest Holdings Group ("NWH Group") against the same scenarios.

 

IFRS 9 Transitional basis

The Group's low point CET1 ratio would have been 11.1% on a minimum stressed ratio basis after the impact of strategic management actions. This is above the Group's 7.0% hurdle rate (please refer to definitions in notes below the table).

 

The Group's Tier 1 leverage ratio would have been 5.2% after the impact of strategic management actions. This is above the hurdle rate of 3.7%.

 

NWH Group's low point CET1 ratio would have been 9.7% on a minimum stressed ratio basis after the impact of strategic management actions. This is above NWH Group's 7.2% hurdle rate.

 

NWH Group's Tier 1 leverage ratio would have been 5.2% after the impact of strategic management actions. This is above the hurdle rate of 3.8%.

 

IFRS 9 Non-transitional basis (fully loaded)

The Group's low point CET1 ratio would have been 11.1% on a minimum stressed ratio basis after the impact of strategic management actions. This is above the Group's 6.2% hurdle rate (please refer to definitions in notes below the table).

 

The Group's Tier 1 leverage ratio would have been 5.1% after the impact of strategic management actions. This is above the hurdle rate of 3.3%.

 

NWH Group's low point CET1 ratio would have been 9.7% on a minimum stressed ratio basis after the impact of strategic management actions. This is above NWH Group's 7.2% hurdle rate.

 

NWH Group's Tier 1 leverage ratio would have been 5.0% after the impact of strategic management actions. This is above the hurdle rate of 3.3%.

 

Commenting on the results, Katie Murray, Chief Financial Officer, said:

 

"The 2022/23 ACS stress testing exercise has once again highlighted NatWest Group's all weather balance sheet enabling us to support our customers and the economy, delivering sustainable value creation and strong distributions for shareholders.

Banks in the UK play a vital role in supporting our economy and these results provide further confidence that we are able to withstand a severe shock; keeping our customers' money safe and continuing to lend, even when times are tough."

Table: Projected consolidated solvency ratios in the stress scenario - NatWest Group

 

Actual(June 2022)

Minimum stressed ratio (before strategic management actions)

Minimum stressed ratio (after the impact of strategic management actions)

Hurdle rate

Actual(March 2023)

IFRS 9 Transitional

 

 

 

Common equity Tier 1 ratio (a) (b)

14.3%

10.3% (g)

11.1%

7.0%

14.4%

Tier 1 capital ratio (c)

16.4%

12.4% (g)

13.2% (g)

16.6%

Total capital ratio (d)

19.3%

15.5% (g)

16.4% (g)

19.6%

Memo: risk-weighted assets (£ bn)

180

214 (g)

207 (g)

178

Memo: CET1 (£ bn)

26

22 (g)

23 (g)

26

Tier 1 leverage ratio (a) (e)

5.2%

5.2% (h)

5.2%

3.7%

5.4%

Memo: leverage exposure (£ bn)

571

571 (h)

571 (h)

544

IFRS 9 non-transitional

Common equity Tier 1 ratio (f)

14.1%

10.5%

11.1%

6.2%

14.3%

Tier 1 leverage ratio(e)(f)

5.1%

4.9%

5.1%

3.3%

5.4%

 

Sources: Participating banks' STDF data submissions.

 

(a) The low points for the common equity Tier 1 (CET1) ratio and leverage ratio shown in the table do not necessarily occur in the same year of the stress scenario and correspond to the year where the minimum stressed ratio is calculated after strategic management actions. There is no conversion of banks' AT1 instruments in the stress.

(b) The CET1 capital ratio is defined as CET1 capital expressed as a percentage of the total risk exposure amount (risk-weighted assets or RWAs), where CET1 capital and RWAs are determined in accordance with the CRR.

(c) The Tier 1 capital ratio is defined as Tier 1 capital expressed as a percentage of RWAs, where Tier 1 capital is defined as the sum of CET1 capital and additional Tier 1 capital determined in accordance with the CRR.

(d) The Total capital ratio is defined as total capital expressed as a percentage of RWAs, where total capital is defined as the sum of Tier 1 capital and Tier 2 capital determined in accordance with the CRR. 

(e) The Tier 1 leverage ratio is Tier 1 capital expressed as a percentage of the leverage exposure measure, as defined in Article 429(2) of the Leverage Ratio (CRR) part of the PRA Rulebook. If a firm does not have sufficient CET1 capital to meet 75% of the leverage ratio minimum requirement and 100% of its leverage ratio buffers (as required by PRA rules), additional Tier 1 capital has been capped at 25% of the leverage ratio minimum requirement for the purpose of calculating the Tier 1 leverage ratio.

(f) The low point year for the non-transitional IFRS 9 may differ to the low point year on a transitional IFRS 9 basis.

(g) Corresponds to the same year as the minimum CET1 ratio over the stress scenario after strategic management actions.

(h) Corresponds to the same year as the minimum leverage ratio over the stress scenario after strategic management actions. 

 

 

For further information, please contact:

 

Investor Relations

+44 (0) 20 7672 1758

 

Media Relations

+44 (0) 131 523 4205

 

 

Forward-Looking Statements

 

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'would have been', 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'will', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as NatWest Group's future economic results, business plans and strategies. In particular, this document may include forward-looking statements relating to NatWest Group plc in respect of, but not limited to: the current economic environment, its economic and political risks, its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital, cost savings and operational targets), the implementation of its purpose-led strategy, its environmental, social and governance and climate-related targets, its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, the transition of LIBOR and IBOR rates to replacement risk free rates and NatWest Group's exposure to operational risk, conduct risk, cyber, data and IT risk, financial crime risk, key person risk and credit rating risk. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or NatWest Group plc's actual results are discussed in NatWest Group plc's 2022 Annual Report on Form 20-F, NatWest Group plc's Interim Management Statement for Q1 2023 on Form 6-K, and its other filings with the US Securities and Exchange Commission. The forward-looking statements contained in this document speak only as of the date of this document and NatWest Group plc does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCRTMFTMTTBMMJ
Date   Source Headline
26th Apr 20245:54 pmRNSPublication of Supplementary Prospectus
26th Apr 202410:30 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSNWG plc Q1 2024 Interim Management Statement
25th Apr 20245:15 pmRNSTransaction in Own Shares
24th Apr 20245:16 pmRNSTransaction in Own Shares
23rd Apr 20245:22 pmRNSTransaction in Own Shares
23rd Apr 20242:22 pmRNSResult of AGM
23rd Apr 20242:02 pmRNSDividend Declaration
23rd Apr 202411:01 amRNSAGM Statement
19th Apr 20245:27 pmRNSTransaction in Own Shares
18th Apr 20245:54 pmRNSTransaction in Own Shares
17th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:15 pmRNSTransaction in Own Shares
12th Apr 20245:12 pmRNSTransaction in Own Shares
11th Apr 20245:10 pmRNSTransaction in Own Shares
11th Apr 202411:43 amRNSBlock Listing Six Monthly Return
10th Apr 20245:15 pmRNSTransaction in Own Shares
9th Apr 20245:20 pmRNSTransaction in Own Shares
8th Apr 20245:35 pmRNSTransaction in Own Shares
5th Apr 202410:32 amRNSHolding(s) in Company - HMT shareholding
4th Apr 20245:39 pmRNSTransaction in Own Shares
4th Apr 20248:00 amRNSDirector Declaration
3rd Apr 20245:13 pmRNSTransaction in Own Shares
3rd Apr 20242:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20246:04 pmRNSTransaction in Own Shares
28th Mar 20245:17 pmRNSTransaction in Own Shares
28th Mar 20241:55 pmRNSTotal Voting Rights
27th Mar 20245:31 pmRNSTransaction in Own Shares
27th Mar 20244:21 pmRNSHolding(s) in Company
25th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 202410:30 amRNSHolding(s) in Company - HMT shareholding
22nd Mar 20245:47 pmRNSTransaction in Own Shares
22nd Mar 20249:30 amRNSDirector Declaration
21st Mar 20245:49 pmRNSTransaction in Own Shares
20th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 20245:47 pmRNSTransaction in Own Shares
19th Mar 20249:01 amRNSHoldings in Company
18th Mar 20245:45 pmRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSNotice of AGM
18th Mar 202412:00 pmRNSDirector/PDMR Shareholding
15th Mar 20245:32 pmRNSTransaction in Own Shares
15th Mar 202410:19 amRNSHolding(s) in Company - HMT shareholding
14th Mar 20245:48 pmRNSTransaction in Own Shares
13th Mar 20245:13 pmRNSTransaction in Own Shares
12th Mar 20245:08 pmRNSTransaction in Own Shares
11th Mar 20245:39 pmRNSTransaction in Own Shares
8th Mar 20245:14 pmRNSTransaction in Own Shares
8th Mar 20242:15 pmRNSDirector/PDMR Shareholding
8th Mar 202412:41 pmRNSHolding(s) in Company
7th Mar 20245:26 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.